Ginsenosides, active ingredients of Panax, can inhibit cellular oxidative stress damage by activating miR-30c-5p and suppressing p53, thus ameliorating myocardial ischemia–reperfusion injury (45). This evidence concerns the gene TP53 and myocardial ischemia.